Bardiès M - Search Results

1

Validation of a personalized dosimetric evaluation tool (Oedipe) for targeted radiotherapy based on the Monte Carlo MCNPX code.

Chiavassa S, Aubineau-Lanièce I, Bitar A, Lisbona A, Barbet J, Franck D, Jourdain JR, Bardiès M. Chiavassa S, et al. Among authors: bardies m. Phys Med Biol. 2006 Feb 7;51(3):601-16. doi: 10.1088/0031-9155/51/3/009. Epub 2006 Jan 11. Phys Med Biol. 2006. PMID: 16424584

2

A simplified approach to alpha dosimetry for small spheres labelled on the surface.

Bardiès M, Myers MJ. Bardiès M, et al. Phys Med Biol. 1990 Nov;35(11):1551-61. doi: 10.1088/0031-9155/35/11/009. Phys Med Biol. 1990. PMID: 2287629

3

Bifunctional antibodies for radioimmunotherapy.

Chatal JF, Faivre-Chauvet A, Bardies M, Peltier P, Gautherot E, Barbet J. Chatal JF, et al. Among authors: bardies m. Hybridoma. 1995 Apr;14(2):125-8. doi: 10.1089/hyb.1995.14.125. Hybridoma. 1995. PMID: 7590767 Review.

4

Computational methods in radionuclide dosimetry.

Bardiès M, Myers MJ. Bardiès M, et al. Phys Med Biol. 1996 Oct;41(10):1941-55. doi: 10.1088/0031-9155/41/10/007. Phys Med Biol. 1996. PMID: 8912373 Review.

5

Bispecific antibody and iodine-131-labeled bivalent hapten dosimetry in patients with medullary thyroid or small-cell lung cancer.

Bardiès M, Bardet S, Faivre-Chauvet A, Peltier P, Douillard JY, Mahé M, Fiche M, Lisbona A, Giacalone F, Meyer P, Gautherot E, Rouvier E, Barbet J, Chatal JF. Bardiès M, et al. J Nucl Med. 1996 Nov;37(11):1853-9. J Nucl Med. 1996. PMID: 8917192 Free article.

6

Radioimmunotherapy in medullary thyroid cancer using bispecific antibody and iodine 131-labeled bivalent hapten: preliminary results of a phase I/II clinical trial.

Kraeber-Bodéré F, Bardet S, Hoefnagel CA, Vieira MR, Vuillez JP, Murat A, Ferreira TC, Bardiès M, Ferrer L, Resche I, Gautherot E, Rouvier E, Barbet J, Chatal JF. Kraeber-Bodéré F, et al. Among authors: bardies m. Clin Cancer Res. 1999 Oct;5(10 Suppl):3190s-3198s. Clin Cancer Res. 1999. PMID: 10541363 Clinical Trial.

7

Production of new thermoluminescent mini-dosimeters.

Martin S, Lisbona A, Richard J, Morteau S, Denizot B, Bardiès M. Martin S, et al. Among authors: bardies m. Phys Med Biol. 2000 Feb;45(2):479-94. doi: 10.1088/0031-9155/45/2/315. Phys Med Biol. 2000. PMID: 10701516

8

Dosimetry and microdosimetry of targeted radiotherapy.

Bardiès M, Pihet P. Bardiès M, et al. Curr Pharm Des. 2000 Sep;6(14):1469-502. doi: 10.2174/1381612003399176. Curr Pharm Des. 2000. PMID: 10903404 Review.

9

Two-step targeting of xenografted colon carcinoma using a bispecific antibody and 188Re-labeled bivalent hapten: biodistribution and dosimetry studies.

Gestin JF, Loussouarn A, Bardiès M, Gautherot E, Gruaz-Guyon A, Saï-Maurel C, Barbet J, Curtet C, Chatal JF, Faivre-Chauvet A. Gestin JF, et al. Among authors: bardies m. J Nucl Med. 2001 Jan;42(1):146-53. J Nucl Med. 2001. PMID: 11197965 Free article.

10

Comparison of four scatter correction methods for patient whole-body imaging during therapeutic trials with iodine-131.

Delpon G, Ferrer L, Lenta C, Lisbona A, Buvat I, Bardiès M. Delpon G, et al. Among authors: bardies m. Cancer. 2002 Feb 15;94(4 Suppl):1224-30. doi: 10.1002/cncr.10289. Cancer. 2002. PMID: 11877749 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

148 results

Search Page

Filters